Moonwalk banks $70m to progress siRNA therapy for obesity
Moonwalk Biosciences has secured $70m in an oversubscribed, Eli Lilly-backed funding round to take its non-incretin obesity candidate to the…
News
“Unparalleled opportunity”: Sandoz embarks on ambitious biosimilar growth strategy
Gilead launches research facility in US for new medicine development
FDA grants RMAT designation to RiboX’s RXRG001 for xerostomia
Why the CNS boom owes its success to breakthroughs in neurological pathologies
Quoin in line for priority review voucher if rare paediatric drug approved
UK on track to reverse years of pharma decline, ABPI report finds
LSTM opens $23m robotic AI lab for infection research
